What You Should Know
The Crisis: A new Harris Poll/Surescripts survey reveals that 56% of U.S. patients face challenges filling prescriptions, with 25% abandoning medication entirely due to cost.The Gap: Despite high digital literacy, only…
Continue Reading
As FHIR advances cost transparency efforts, ‘knowledge is power’ | Healthcare IT News…
Continue Reading
What You Should Know
– Today, President Donald J. Trump has launched “The Great Healthcare Plan,” a sweeping initiative designed to lower prescription drug costs to the lowest international levels and reduce insurance premiums by…
Continue Reading
Deepanshu Saini, Director of Program Management at IQVIA
Pharmaceutical companies are tasked with managing vast volumes of patient data, product information and safety reports. Yet, much of this valuable intelligence remains buried in transcripts, call…
Continue Reading
Lani Bertrand, Sr. Director, Clinical Marketing & Thought Leadership at Omnicell
We’ve all been there: one weekend, you’re bitten by the home improvement bug. A few clicks later, your online cart is full of tools,…
Continue Reading
Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and possibly at less expense.Pharma first started using artificial intelligence in the clinical and development…
Continue Reading
Ana Pedro Jesuíno, Marketed Product Safety Associate Director, IQVIA
Pharmacovigilance (PV) is experiencing a renaissance. Artificial Intelligence (AI) is no longer a futuristic concept in PV; it’s here, reshaping how we manage safety data, detect…
Continue Reading
As we peer into the healthcare horizon of 2026, a singular theme crystallizes among industry leaders: the transition from aspirational innovation to operational necessity. The executive predictions for the coming year depict a sector…
Continue Reading
Trust and transparency drive optimization of OR workflows | MobiHealthNews
Skip to main content…
Continue Reading
What You Should Know:
– New analysis of Texas hospital price data reveals a transparency paradox: discounted cash prices for common services are often significantly lower than the rates hospitals negotiated with commercial insurers, according…
Continue Reading
